Risk stratification of upper tract urothelial carcinoma: A Review of the Current Literature

References

• Roupret M, Babjuk M, Comperat E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018 Jan;73(1):111–122.
   PubMed Web of Science ®Google Scholar
• Chromecki TF, Bensalah K, Remzi M, et al. Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol. 2011 Jul 5;8(8):440–447.
   PubMed Web of Science ®Google Scholar
• Woodford R, Ranasinghe W, Aw HC, et al. Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria–Australia. BJU Int. 2016 Apr;117(Suppl 4):45–49.
   PubMedGoogle Scholar
• Luo Y, She DL, Xiong H, et al. Kidney-sparing Management versus nephroureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2015;16(14):5907–5912.
   PubMedGoogle Scholar
• Seisen T, Colin P, Roupret M. Risk-adapted strategy for the kidney-sparing management of upper tract tumours. Nat Rev Urol. 2015 Mar;12(3):155–166.
   PubMed Web of Science ®Google Scholar
• Chromecki TF, Ehdaie B, Novara G, et al. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol. 2011 Aug;29(4):473–480.
   PubMed Web of Science ®Google Scholar
• Fernandez MI, Shariat SF, Margulis V, et al. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology. 2009 Jan;73(1):142–146.
   PubMed Web of Science ®Google Scholar
• Inamoto T, Matsuyama H, Ibuki N, et al. Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study. Ther Adv Urol. 2018 Dec;10(12):403–410.
   PubMed Web of Science ®Google Scholar
• Kim HS, Jeong CW, Kwak C, et al. Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis. Oncotarget. 2017 Jan 31;8(5):7464–7476.
   PubMedGoogle Scholar
• Gakis G, Schubert T, Alemozaffar M, et al. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World J Urol. 2017 Mar;35(3):327–335.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Godoy G, Lotan Y, et al. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int. 2010 Jun;105(12):1672–1677.
   PubMed Web of Science ®Google Scholar
• Yap SA, Schupp CW, Chamie K, et al. Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes. Urology. 2011 Jul;78(1):87–92.
   PubMed Web of Science ®Google Scholar
• Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer. 2009 Mar 15;115(6):1224–1233.
   PubMed Web of Science ®Google Scholar
• Xylinas E, Kluth L, Passoni N, et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014 Mar;65(3):650–658.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011 Aug;29(4):481–486.
   PubMed Web of Science ®Google Scholar
• Li CC, Chang TH, Wu WJ, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol. 2008 Nov;54(5):1127–1134.
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Sun M, Perrotte P, et al. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the surveillance, epidemiology, and end results database. Urology. 2010 Feb;75(2):321–327.
   PubMed Web of Science ®Google Scholar
• Wang L-J, Chou W-C, Pang S-T, et al. Risk stratification of upper urinary tract urothelial carcinoma patients for survival prediction: a simple summation scoring method. J Cancer. 2018;9(13):2284–2294.
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Kikuchi E, Tanaka N, et al. Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. J Urol. 2013 Jun;189(6):2062–2068.
   PubMed Web of Science ®Google Scholar
• Rink M, Xylinas E, Margulis V, et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol. 2013 Jun;63(6):1082–1090.
   PubMed Web of Science ®Google Scholar
• van Osch FH, Jochems SH, van Schooten FJ, et al. Significant role of lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis. J Urol. 2016 Apr;195(4 Pt 1):872–879.
   PubMed Web of Science ®Google Scholar
• Xylinas E, Kluth LA, Rieken M, et al. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2014 Jul;114(1):56–61.
   PubMed Web of Science ®Google Scholar
• Xia L, Taylor BL, Pulido JE, et al. Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: A national cancer database study. Urol Oncol. 2018 Jan;36(1):10.e15-10.e22.
   PubMed Web of Science ®Google Scholar
• Sundi D, Svatek RS, Margulis V, et al. Upper tract urothelial carcinoma: impact of time to surgery. Urol Oncol. 2012 May-June;30(3):266–272.
   PubMed Web of Science ®Google Scholar
• Lee JN, Kwon SY, Choi GS, et al. Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma. J Surg Oncol. 2014 Sep;110(4):468–475.
   PubMed Web of Science ®Google Scholar
• Waldert M, Karakiewicz PI, Raman JD, et al. A delay in radical nephroureterectomy can lead to upstaging. BJU Int. 2010 Mar;105(6):812–817.
   PubMed Web of Science ®Google Scholar
• Altan M, Haberal HB, Akdogan B, et al. A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma. Int J Clin Oncol. 2017 Oct;22(5):964–971.
   PubMed Web of Science ®Google Scholar
• Kohada Y, Hayashi T, Goto K, et al. Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma. Jpn J Clin Oncol. 2018 Sep 1;48(9):841–850.
   PubMed Web of Science ®Google Scholar
• Li X, Ma X, Tang L, et al. Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis. Oncotarget. 2017 Sep 22;8(37):62681–62692.
   PubMedGoogle Scholar
• Marchioni M, Cindolo L, Autorino R, et al. High neutrophil-to-lymphocyte ratio as prognostic factor in patients affected by upper tract urothelial cancer: a systematic review and meta-analysis. Clin Genitourin Cancer. 2017 Jun;15(3):343–349.e1.
   PubMed Web of Science ®Google Scholar
• Vartolomei MD, Kimura S, Ferro M, et al. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients. World J Urol. 2018 Jul;36(7):1019–1029.
   PubMed Web of Science ®Google Scholar
• Dalpiaz O, Pichler M, Mannweiler S, et al. Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. Br J Cancer. 2014 May 13;110(10):2531–2536.
   PubMed Web of Science ®Google Scholar
• Vartolomei MD, Mathieu R, Margulis V, et al. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. World J Urol. 2017 Jan;35(1):121–130.
   PubMed Web of Science ®Google Scholar
• Liu P, Su XH, Xiong GY, et al. Diagnostic ureteroscopy for upper tract urothelial carcinoma is independently associated with intravesical recurrence after radical nephroureterectomy. Int Braz J Urol. 2016 Nov-Dec;42(6):1129–1135.
   PubMed Web of Science ®Google Scholar
• Sung HH, Jeon HG, Han DH, et al. Diagnostic ureterorenoscopy is associated with increased intravesical recurrence following radical nephroureterectomy in upper tract urothelial carcinoma. PloS One. 2015;10(11):e0139976.
   PubMed Web of Science ®Google Scholar
• Tan P, Xie N, Yang L, et al. Diagnostic ureteroscopy prior to radical nephroureterectomy for upper tract urothelial carcinoma increased the risk of intravesical recurrence. Urol Int. 2018;100(1):92–99.
   PubMed Web of Science ®Google Scholar
• Guo RQ, Hong P, Xiong GY, et al. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int. 2018 Feb;121(2):184–193.
   PubMed Web of Science ®Google Scholar
• Marchioni M, Primiceri G, Cindolo L, et al. Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int. 2017 Sep;120(3):313–319.
   PubMed Web of Science ®Google Scholar
• Yoo S, You D, Song C, et al. Risk of intravesical recurrence after ureteroscopic biopsy for upper tract urothelial carcinoma: does the Location matter? J Endourol. 2017 Mar;31(3):259–265.
   PubMed Web of Science ®Google Scholar
• Lee HY, Yeh HC, Wu WJ, et al. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence. World J Surg Oncol. 2018 Jul 9;16(1):135.
   PubMedGoogle Scholar
• Joglekar S, Nau PN, Mezhir JJ. The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature. J Surg Oncol. 2015 Oct;112(5):503–509.
   PubMed Web of Science ®Google Scholar
• Anno T, Kikuchi E, Fukumoto K, et al. Preoperative sarcopenia status is associated with lymphovascular invasion in upper tract urothelial carcinoma patients treated with radical nephroureterectomy. Can Urol Assoc J. 2018 Mar;12(3):E132–e136.
   PubMed Web of Science ®Google Scholar
• Fukushima H, Nakanishi Y, Kataoka M, et al. Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy. Cancer Med. 2016 Sep;5(9):2213–2220.
   PubMed Web of Science ®Google Scholar
• Ishihara H, Kondo T, Omae K, et al. Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study. Int J Clin Oncol. 2017 Feb;22(1):136–144.
   PubMed Web of Science ®Google Scholar
• Kocher NJ, Jafri S, Balabhadra S, et al. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy? Urol Oncol. 2018 Apr;36(4):156.e17-156.e22.
   Web of Science ®Google Scholar
• Remzi M, Haitel A, Margulis V, et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int. 2009 Feb;103(3):307–311.
   PubMed Web of Science ®Google Scholar
• Mbeutcha A, Roupret M, Kamat AM, et al. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. World J Urol. 2017 Mar;35(3):337–353.
   PubMed Web of Science ®Google Scholar
• Kamihira O, Hattori R, Yamaguchi A, et al. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol. 2009 Jun;55(6):1397–1407.
   PubMed Web of Science ®Google Scholar
• Inman BA, Tran VT, Fradet Y, et al. Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer. 2009 Jul 1;115(13):2853–2862.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Zigeuner R, Rink M, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol. 2012 Aug;62(2):224–231.
   PubMed Web of Science ®Google Scholar
• Kim HS, Jeong CW, Kwak C, et al. Can body mass index predict survival outcomes in patients treated with radical nephroureterectomy for upper-tract urothelial carcinoma? Int Urol Nephrol. 2015 Aug;47(8):1311–1320.
   PubMed Web of Science ®Google Scholar
• Shibing Y, Liangren L, Qiang W, et al. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases. BJU Int. 2016 Dec;118(6):902–910.
   PubMed Web of Science ®Google Scholar
• Bier S, Hennenlotter J, Esser M, et al. Performance of urinary markers for detection of upper tract urothelial carcinoma: is upper tract urine more accurate than urine from the bladder? Dis Markers. 2018;2018:5823870.
   PubMedGoogle Scholar
• Chen L, He H, Zarka MA, et al. Upper tract urinary cytology to detect upper tract urothelial carcinoma: using the Johns Hopkins Hospital template and evaluation of its feasibility. CytoJournal. 2015;12:17.
   PubMed Web of Science ®Google Scholar
• Horovitz D, Meng Y, Joseph JV, et al. The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory. Can Urol Assoc J. 2017 Jul;11(7):E285–e290.
   PubMed Web of Science ®Google Scholar
• Sakano S, Inamoto T, Inoue R, et al. Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy? Jpn J Clin Oncol. 2015 Oct;45(10):968–972.
   PubMed Web of Science ®Google Scholar
• Seisen T, Granger B, Colin P, et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol. 2015 Jun;67(6):1122–1133.
   PubMed Web of Science ®Google Scholar
• Brien JC, Shariat SF, Herman MP, et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol. 2010 Jul;184(1):69–73.
   PubMed Web of Science ®Google Scholar
• Potretzke AM, Knight BA, Potretzke TA, et al. Is ureteroscopy needed prior to nephroureterectomy? An evidence-based algorithmic approach. Urology. 2016;88:43–48.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Konrad AJ, Kawashima A, et al. CT urography for diagnosis of upper urinary tract urothelial carcinoma: are both nephrographic and excretory phases necessary? Ajr. 2015 Sep;205(3):W320–7.
   PubMed Web of Science ®Google Scholar
• Brown GA, Matin SF, Busby JE, et al. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology. 2007 Aug;70(2):252–256.
   PubMed Web of Science ®Google Scholar
• Guarnizo E, Pavlovich CP, Seiba M, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol. 2000 Jan;163(1):52–55.
   PubMed Web of Science ®Google Scholar
• Hanna L, Chung V, Ali A, et al. Ureteroscopy in the diagnosis of upper tract transitional cell cancer: a 10-year experience providing outcome data for informed consent. Urologia. 2017;84(4):254-258.
   PubMed Web of Science ®Google Scholar
• Cutress ML, Stewart GD, Zakikhani P, et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012 Sep;110(5):614–628.
   PubMed Web of Science ®Google Scholar
• Cha EK, Shariat SF, Kormaksson M, et al. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2012 Apr;61(4):818–825.
   PubMed Web of Science ®Google Scholar
• Novara G, De Marco V, Gottardo F, et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer. 2007 Oct 15;110(8):1715–1722.
   PubMed Web of Science ®Google Scholar
• Li WM, Li CC, Ke HL, et al. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol. 2009 Aug;182(2):451–8;discussion 458.
   Web of Science ®Google Scholar
• Krabbe LM, Eminaga O, Shariat SF, et al. Postoperative nomogram for relapse-free survival in patients with high grade upper tract urothelial carcinoma. J Urol. 2017 Mar;197(3 Pt 1):580–589.
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012 Jul;62(1):100–114.
   PubMed Web of Science ®Google Scholar
• Ito Y, Kikuchi E, Tanaka N, et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol. 2011 May;185(5):1621–1626.
   PubMed Web of Science ®Google Scholar
• Cowan NC, Turney BW, Taylor NJ, et al. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int. 2007 Jun;99(6):1363–1370.
   PubMed Web of Science ®Google Scholar
• Pieras E, Frontera G, Ruiz X, et al. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int. 2010 Nov;106(9):1319–1323.
   PubMed Web of Science ®Google Scholar
• Simone G, Papalia R, Loreto A, et al. Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int. 2009 Apr;103(8):1052–1057.
   PubMed Web of Science ®Google Scholar
• Su X, Fang D, Li X, et al. The influence of tumor size on oncologic outcomes for patients with upper tract urothelial carcinoma after radical nephroureterectomy. Biomed Res Int. 2016;2016:4368943.
   PubMed Web of Science ®Google Scholar
• Chromecki TF, Cha EK, Fajkovic H, et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol. 2012 Feb;61(2):245–253.
   PubMed Web of Science ®Google Scholar
• Baard J, de Bruin DM, Zondervan PJ, et al. Diagnostic dilemmas in patients with upper tract urothelial carcinoma. Nat Rev Urol. 2017 Mar;14(3):181–191.
   PubMed Web of Science ®Google Scholar
• Raman JD, Ng CK, Scherr DS, et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol. 2010 Jun;57(6):1072–1079.
   PubMed Web of Science ®Google Scholar
• Yafi FA, Novara G, Shariat SF, et al. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int. 2012 Jul;110(2 Pt 2):E7–13.
   PubMedGoogle Scholar
• Yoo S, You D, Jeong IG, et al. Impact of tumor location on local recurrence after nephroureterectomy for upper tract urothelial carcinoma: implications for adjuvant radiotherapy. Clin Genitourin Cancer. 2017 Apr;15(2):e199–e204.
   PubMedGoogle Scholar
• Favaretto RL, Shariat SF, Chade DC, et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at memorial sloan-kettering cancer center. Eur Urol. 2010 Oct;58(4):574–580.
   PubMed Web of Science ®Google Scholar
• Ouzzane A, Colin P, Xylinas E, et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol. 2011 Dec;60(6):1258–1265.
   PubMed Web of Science ®Google Scholar
• Williams AK, Kassouf W, Chin J, et al. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urol Oncol. 2013 Oct;31(7):1161–1165.
   PubMed Web of Science ®Google Scholar
• Akdogan B, Dogan HS, Eskicorapci SY, et al. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol. 2006 Jul;176(1):48–52.
   PubMed Web of Science ®Google Scholar
• Rink M, Ehdaie B, Cha EK, et al. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol. 2012 Oct;62(4):677–684.
   PubMed Web of Science ®Google Scholar
• Danzig MR, Mallin K, McKiernan JM, et al. Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis. Cancer. 2018 Jun 15;124(12):2507–2514.
   PubMed Web of Science ®Google Scholar
• Godfrey MS, Badalato GM, Hruby GW, et al. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion. BJU Int. 2012 Sep;110(6):798–803.
   PubMed Web of Science ®Google Scholar
• Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009 Feb 1;27(4):612–618.
   PubMed Web of Science ®Google Scholar
• Mellouli M, Charfi S, Smaoui W, et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract. Urol J. 2017 Aug 29;14(5):5008–5012.
   PubMed Web of Science ®Google Scholar
• Novara G, Matsumoto K, Kassouf W, et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol. 2010 Jun;57(6):1064–1071.
   PubMed Web of Science ®Google Scholar
• Kimura S, Mari A, Foerster B, et al. Prognostic value of concomitant carcinoma in situ in the radical cystectomy specimen: a systematic review and meta-analysis. J Urol. 2019 Jan;201(1):46–53.
   PubMed Web of Science ®Google Scholar
• Wheat JC, Weizer AZ, Wolf JS Jr., et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol. 2012 May-June;30(3):252–258.
   PubMed Web of Science ®Google Scholar
• Otto W, Shariat SF, Fritsche HM, et al. Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol. 2011 Aug;29(4):487–494.
   PubMed Web of Science ®Google Scholar
• Inamoto T, Matsuyama H, Ibuki N, et al. Biological behavior and long-term outcomes of carcinoma in situ in upper urinary tract managed by radical nephroureterectomy. J Urol. 2018 Apr;199(4):933–939.
   PubMed Web of Science ®Google Scholar
• Chen XP, Xiong GY, Li XS, et al. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China. BJU Int. 2013 Nov;112(7):917–924.
   PubMed Web of Science ®Google Scholar
• Fan B, Hu B, Yuan Q, et al. Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy. Tumour Biol. 2017 Jul;39(7):1010428317710822.
   Google Scholar
• Colin P, Ouzzane A, Yates DR, et al. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol. 2012 Oct;19(11):3613–3620.
   PubMed Web of Science ®Google Scholar
• Abouassaly R, Alibhai SM, Shah N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology. 2010 Oct;76(4):895–901.
   PubMed Web of Science ®Google Scholar
• Hurel S, Roupret M, Ouzzane A, et al. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2013 Jun;111(8):1199–1207.
   PubMed Web of Science ®Google Scholar
• Fajkovic H, Cha EK, Jeldres C, et al. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. J Urol. 2012 Mar;187(3):845–851.
   PubMed Web of Science ®Google Scholar
• Ehdaie B, Chromecki TF, Lee RK, et al. Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol. 2011 Jul;186(1):66–72.
   PubMed Web of Science ®Google Scholar
• Nazzani S, Mazzone E, Preisser F, et al. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma. Eur J Surg Oncol. 2018 Dec 11.
   Web of Science ®Google Scholar
• Dominguez-Escrig JL, Peyronnet B, Seisen T, et al. Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European association of urology guidelines panel on non-muscle-invasive bladder cancer. In: European urology focus. 2019 Mar;5(2):224-241.
   Google Scholar
• Roscigno M, Brausi M, Heidenreich A, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol. 2011 Oct;60(4):776–783.
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Jeldres C, Isbarn H, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2010 Jan;75(1):118–124.
   PubMed Web of Science ®Google Scholar
• Roscigno M, Shariat SF, Margulis V, et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol. 2009 Sep;56(3):512–518.
   PubMed Web of Science ®Google Scholar
• Moschini M, Foerster B, Abufaraj M, et al. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World J Urol. 2017 Oct;35(10):1541–1547.
   PubMed Web of Science ®Google Scholar
• Zhang XK, Zhang ZL, Yang P, et al. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma. Jpn J Clin Oncol. 2015 Nov;45(11):1069–1075.
   PubMed Web of Science ®Google Scholar
• Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 2010 Apr;57(4):575–581.
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–264.
   PubMed Web of Science ®Google Scholar
• Morita K, Oda M, Koyanagi M, et al. Metastatic brain tumor from urothelial carcinoma of the prostatic urethra. Surg Neurol Int. 2016;7(Suppl 17):S488–91.
   PubMedGoogle Scholar
• Su X, Hao H, Li X, et al. Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma. Oncotarget. 2017 Apr 18;8(16):26106–26111.
   PubMedGoogle Scholar
• Krabbe LM, Heitplatz B, Preuss S, et al. Prognostic value of PD-1 and PD-L1 expression in patients with high grade upper tract urothelial carcinoma. J Urol. 2017 Dec;198(6):1253–1262.
   PubMed Web of Science ®Google Scholar
• Miyama Y, Morikawa T, Miyakawa J, et al. The prognostic value of PD-L1 expression in upper tract urothelial carcinoma varies according to platelet count. Cancer Med. 2018 Sep;7(9):4330–4338.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yu W, Feng X, et al. Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma. Med Oncol. 2017 May;34(5):94.
   PubMed Web of Science ®Google Scholar
• Bellmunt J, Mullane SA, Werner L, et al. Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma. Ann Oncol. 2015 Apr;26(4):812–817.
   PubMed Web of Science ®Google Scholar
• Guan B, Xing Y, Xiong G, et al. Predictive value of gene methylation for second recurrence following surgical treatment of first bladder recurrence of a primary upper-tract urothelial carcinoma. Oncol Lett. 2018 Jun;15(6):9397–9405.
   PubMed Web of Science ®Google Scholar
• Luo HL, Chiang PH, Huang CC, et al. Methylation of SPARCL1 is associated with oncologic outcome of advanced upper urinary tract urothelial carcinoma. Int J Mol Sci. 2019 Apr 3;20:7.
   Web of Science ®Google Scholar
• Lin JT, Chan TC, Li CF, et al. Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. APMIS. 2019 Apr;127(4):170–180.
   PubMed Web of Science ®Google Scholar
• Li WM, Huang CN, Lee YC, et al. Over-expression of activated signal transducer and activator of transcription 3 predicts poor prognosis in upper tract urothelial carcinoma. Int J Med Sci. 2017;14(13):1360–1367.
   PubMed Web of Science ®Google Scholar
• Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol. 2016 Dec;70(6):1052–1068.
   PubMed Web of Science ®Google Scholar